Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma - Concepedia

Concepedia

Publication | Closed Access

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

1.3K

Citations

19

References

2000

Year

Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson, Gerhard Fierlbeck, Wolfgang Tilgen, Simone Seiter, Martin Gore, Steinar Aamdal, Jonathan Cebon, A. Coates,

Journal of Clinical Oncology

Abstract

Temozolomide demonstrates efficacy equal to that of DTIC and is an oral alternative for patients with advanced metastatic melanoma.

References

	Year	Citations

Page 1